Carisma Therapeutics, Inc.

Q3 2023 13F Holders

Symbol
CARM
CUSIP
14216R101
Type
Equity
Class
COM
Num filers
61
Total reported value, excl. options
$32.2M
Manager Report Date Value ($000) Shares